Replies to post #314559 on Avid Bioservices Inc (CDMO)

[biopharm]

So Dr Bernard Fox working with Peregrine re: Immune profiling....now just stresses the importance of BIOMARKERS in a meeting called on recently....

“Now is the time to have this meeting, “ Fox said. “I applaud NIBIT for gathering academic investigators, important foundations and companies that are developing anti-OX40 and other T cell agonists to discuss conceptsaround dose, schedule, biomarkers, microbiome and the metabolome.”

....and remember, Dr Fox stressed the dangers of OX40 here just in Aug 28 2017

PUBLIC RELEASE: 28-AUG-2017
Concurrent treatment with OX40- and PD1-targeted cancer immunotherapies may be detrimental
..
..
https://www.eurekalert.org/pub_releases/2017-08/aafc-ctw082317.php

Something is up....

This becomes a little shocking. Now, Dr. Wolchok has been working with platforms from the late (both young..) Dr. Philip Thorpe / Dr. Andrew Parsa.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=118503440

Something is really up as I think Merck may be behind the hail Mary attempt by Ronin Capital Management ....and Dr Rolf Brekken reminding us of increased responders and decreased toxicties ..and if Merck is with Ronin hedge fund group....who is Gilead with?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=130496957